Cagrilintide 5mg
Size: 5mg | 99% Purity
M.Wt: 4577.5
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: ~7 days
CAS No.: 1415456-99-3
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 4577.5 g/mol |
| CAS number | 1415456-99-3 |
| Synonyms | Cagrilintide, AM833 |
| Solubility | H2O |
| Storage | -20°C / 3 years |
| Half-life | ~7 days |
★ Bestseller
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 5 mg)
Back-in-stock notification
Out of stock. Leave your email and we will notify you when it returns.
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
Cagrilintide 5mg — research reference material
Cagrilintide 5mg is supplied by NMChem as a research reference material in a 5mg presentation. Compound class: Amylin analogue · 37-residue peptide, characterised in the literature as a amylin/calcitonin receptor agonist. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
Research context
Amylin analog; studied in appetite / metabolic-weight research. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our Cagrilintide research reference. Related compounds in the same research area: Semaglutide, Tirzepatide, Retatrutide. You can also compare it side by side on our comparison tool.
Presentation
This listing is the 5mg presentation at >99% stated purity, catalogue reference CAG5.
Identifiers
- CAS number: 1415456-99-3
- Molecular weight: 4577.5 g/mol
- Synonyms: Cagrilintide, AM833
- Class: Amylin analogue · 37-residue peptide
Format & quality
Supplied as 5mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
Storage
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch. Reported half-life in the research literature: ~7 days.
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. NMChem supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
Frequently asked questions
What is Cagrilintide 5mg?
Amylin analogue · 37-residue peptide. Amylin analog; studied in appetite / metabolic-weight research. NMChem supplies it as a research reference material only.
What is the CAS number for Cagrilintide 5mg?
1415456-99-3. Molecular weight 4577.5 g/mol.
How should Cagrilintide 5mg be stored?
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity.
Garvey WT et al. · The New England journal of medicine · 2025
PubMed PMID 40544433 -
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.
Davies MJ et al. · The New England journal of medicine · 2025
PubMed PMID 40544432 -
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
Lau DCW et al. · Lancet (London, England) · 2021
PubMed PMID 34798060
You may also need
